Literature DB >> 15254213

Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1.

Jyotsna Pandya1, Dennis M Walling.   

Abstract

This study examined the effect of naturally occurring Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene sequence variation on the LMP-1 half-life in epithelial cells. The LMP-1 half-life was not influenced by sequence variation in amino acids 250 to 307 or amino acids 343 to 352. The LMP-1 half-life was short when the amino acid encoded at position 129 was methionine, the initiation codon product of lytic LMP-1 (lyLMP-1). The mutation of amino acid 129 to isoleucine greatly increased the LMP-1 half-life. Expression of lyLMP-1 in trans down-regulated the LMP-1 half-life in a dose-dependent manner and restored a short-half-life phenotype to the mutated LMP-1 construct lacking the cis ability to express lyLMP-1. This observed dominant negative effect of lyLMP-1 expression on the LMP-1 half-life in epithelial cells in vitro may have implications for EBV epithelial oncogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254213      PMCID: PMC446115          DOI: 10.1128/JVI.78.15.8404-8410.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation.

Authors:  Jau-Song Yu; Hsing-Chen Tsai; Chih-Ching Wu; Li-Ping Weng; Hsin-Pai Li; Pei-Jung Chung; Yu-Sun Chang
Journal:  Oncogene       Date:  2002-11-14       Impact factor: 9.867

2.  Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.

Authors:  Dennis M Walling; Paul D Ling; Alexey V Gordadze; Miguel Montes-Walters; Catherine M Flaitz; C Mark Nichols
Journal:  J Infect Dis       Date:  2004-06-11       Impact factor: 5.226

3.  Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1.

Authors:  Barbara Adler; Eveline Schaadt; Bettina Kempkes; Ursula Zimber-Strobl; Barbara Baier; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8.

Authors:  G S Hudson; P J Farrell; B G Barrell
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

5.  The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.

Authors:  Masaya Higuchi; Elliott Kieff; Kenneth M Izumi
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

Authors:  Stuart Prince; Sinead Keating; Ceri Fielding; Paul Brennan; Eike Floettmann; Martin Rowe
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions.

Authors:  Golnar Vazirabadi; Timothy R Geiger; William F Coffin Iii; Jennifer M Martin
Journal:  J Gen Virol       Date:  2003-08       Impact factor: 3.891

8.  Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.

Authors:  Dennis M Walling; Catherine M Flaitz; C Mark Nichols
Journal:  J Infect Dis       Date:  2003-09-03       Impact factor: 5.226

9.  Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.

Authors:  Kimberly D Erickson; Christoph Berger; William F Coffin; Edwin Schiff; Dennis M Walling; Jennifer M Martin
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation.

Authors:  Weigang Tang; Oleg A Pavlish; Vladimir S Spiegelman; Andrey A Parkhitko; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

View more
  6 in total

1.  Oncogenic activity of Epstein-Barr virus latent membrane protein 1 (LMP-1) is down-regulated by lytic LMP-1.

Authors:  Jyotsna Pandya; Dennis M Walling
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma.

Authors:  Masayoshi Nagamine; Miki Takahara; Kan Kishibe; Toshihiro Nagato; Hideyuki Ishii; Nobuyuki Bandoh; Takeshi Ogino; Yasuaki Harabuchi
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

3.  A new model of LMP1-MYC interaction in B cell lymphoma.

Authors:  Evelena P Ontiveros; Ahmad Halwani; Laura L Stunz; Natalie Kamberos; Alicia K Olivier; Siegfried Janz; Gail A Bishop
Journal:  Leuk Lymphoma       Date:  2014-04-23

Review 4.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580

Review 5.  Oncogenes and RNA splicing of human tumor viruses.

Authors:  Masahiko Ajiro; Zhi-Ming Zheng
Journal:  Emerg Microbes Infect       Date:  2014-09-03       Impact factor: 7.163

6.  Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  Siddhesh Aras; Gyanendra Singh; Kenneth Johnston; Timothy Foster; Ashok Aiyar
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.